Month: August 2023
-
Trial Underway Testing Stem Cell Particles for Burns
A clinical trial has begun testing an experimental treatment for burns using off-the-shelf therapeutic particles derived from human bone marrow stem cells.
-
Advanced Encryption Shown to Enable Cancer Data Sharing
Data scientists and cancer specialists demonstrate a data encryption technique that makes possible real-world cancer data sharing while preserving individual privacy.
-
Industry, Univ. Labs Partner on Parkinson’s Digital Biomarkers
A developer of electronic health data tools and a university’s neuroscience labs are collaborating on tests of Parkinson’s disease drugs using digital measures of patient functioning.
-
Infographic – Some Good Corporate Venture Fund News
Since the start of 2021, most news has been gloomy about venture investments, but a report last week suggests corporate venture capital funding worldwide is picking up.
-
Health App Shown to Improve Asthma, Depression Outcomes
Findings from two clinical trials show a digital health mobile app helps improve outcomes and manage the conditions for people with depression and asthma.
-
Regeneron Acquires Hearing Loss Biotech in $213M Deal
Regeneron Pharmaceuticals, a maker of synthetic biologic treatments, is acquiring Decibel Therapeutics, developer of gene therapies to treat hearing loss and balance disorders.
-
Companies to Assess Ovarian Health Biotech Drug
A women’s health biotechnology company is partnering with a Brazilian drug maker to evaluate a precision target and treatment for ovarian health disorders.
-
Trial Shows Vaccine Induces Chikungunya Immune Response
Initial findings from a large clinical trial testing a vaccine against the chikungunya virus show the vaccine generates protective antibodies in the vast majority of recipients.
-
Infographic – Growing Climate Crisis Economic Burden
In the last three decades, according to the analysis, the economic burden jumped markedly from before, rising to nearly $1.5 trillion worldwide in the years 2010 to 2019.
-
Long-Acting Drug Start-Up Raises $4M in Seed Funds
A new company with a process using artificial intelligence and robotics to speed development of sustained release drugs is raising $4 million in seed funds.